News

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...
Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.
Moderna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc PFE and BioNTech SE BNTX over the Covid-19 vaccine. ...
Pfizer Inc PFE, BioNTech SE BNTX, and Moderna Inc MRNA were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The ...
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that ...
CAMBRIDGE, Mass. — COVID-19 vaccine partners Pfizer and BioNTech are countersuing Cambridge-based Moderna in an ongoing fight over the technology used in the shots.
Moderna and Pfizer/BioNTech earned more than $110 billion from their COVID vaccines. Read how patent infringement cases could impact their respective businesses.
Moderna sues Pfizer and BioNTech over coronavirus vaccine patent Lawsuit sets up clash between rival vaccine makers who used novel mRNA technology to battle covid August 26, 2022 More than 2 years ago ...
Moderna sued Pfizer and its German partner BioNTech on Friday, alleging the rival firms improperly used its foundational technology in developing their coronavirus vaccine.
COVID-19 vaccine maker Biontech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S ...
(Reuters) -The biotech company that makes mRNA-delivery technology for Pfizer's COVID-19 vaccine sued Arbutus Biopharma Corp in Manhattan federal court on Friday, seeking to head off claims that ...